Oncosec Medical (ONCS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ONCS | AMGN | VRTX | REGN | GSK |
| Company | Oncosec Medical | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.3529 | 306.42 | 451.90 | 984.04 | 45.42 |
| High | 0.3972 | 307.50 | 457.66 | 993.73 | 45.45 |
| Low | 0.2520 | 303.90 | 449.42 | 983.16 | 45.03 |
| Last | 0.2772 | 306.88 | 455.95 | 994.83 | 45.22 |
| Change | +0.0670 | +0.38 | +5.15 | +14.26 | +0.07 |
| % Change | +31.87% | +0.12% | +1.14% | +1.45% | +0.16% |
| Volume | 52,491,000 | 527,965 | 372,700 | 92,632 | 985,685 |
| 20-Day Average Volume | 4,069,205 | 2,773,275 | 1,127,776 | 416,500 | 3,869,051 |
| Previous Close | 0.2102 | 306.50 | 450.80 | 980.57 | 45.15 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3732 | 303.29 | 424.48 | 961.79 | 44.27 |
| 20-Day Raw Stochastic | 30.50% | 70.62% | 97.21% | 95.45% | 83.35% |
| 20-Day Relative Strength | 32.70% | 58.43% | 73.99% | 61.69% | 62.58% |
| Weighted Alpha | -93.96 | +37.59 | +40.33 | +36.50 | +35.44 |
| Today's Opinion | 100% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 72% Sell | 8% Buy | 8% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +28.16% since 06/15/23 | -1.80% since 05/17/24 | +2.38% since 05/17/24 | +1.06% since 05/17/24 | +0.43% since 05/17/24 |
| Low | 0.1800 on 06/22/23 | 303.90 on 05/24/24 | 437.46 on 05/21/24 | 975.73 on 05/23/24 | 44.40 on 05/20/24 |
| High | 0.3972 on 06/23/23 | 316.67 on 05/21/24 | 457.66 on 05/24/24 | 997.87 on 05/22/24 | 45.79 on 05/22/24 |
| 1-Month | |||||
| %Chg | -45.66% since 05/23/23 | +12.40% since 04/24/24 | +13.74% since 04/24/24 | +9.50% since 04/24/24 | +10.56% since 04/24/24 |
| Low | 0.1800 on 06/22/23 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 40.81 on 04/25/24 |
| High | 0.5100 on 05/24/23 | 322.60 on 05/03/24 | 457.66 on 05/24/24 | 997.87 on 05/22/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -87.57% since 03/23/23 | +6.11% since 02/23/24 | +5.98% since 02/23/24 | +1.17% since 02/23/24 | +7.00% since 02/23/24 |
| Low | 0.1800 on 06/22/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 3.2900 on 03/27/23 | 322.60 on 05/03/24 | 457.66 on 05/24/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -84.07% since 12/23/22 | +15.59% since 11/24/23 | +29.11% since 11/24/23 | +24.35% since 11/24/23 | +26.15% since 11/24/23 |
| Low | 0.1800 on 06/22/23 | 260.68 on 04/19/24 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.35 on 11/29/23 |
| High | 3.4900 on 03/14/23 | 329.72 on 02/05/24 | 457.66 on 05/24/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,262 | 164,417,328 | 116,330,288 | 108,045,080 | 93,570,672 |
| Shares Outstanding, K | 4,554 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -34,180,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -6,860,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.99 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.65 on 03/13/23 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 06/27/23 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 29.72 | 26.51 | 11.33 |